Go to deals
Saúde

IMD International Medical Devices has aised funds

IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implementing a growth strategy, both in Italy and abroad.

IMD International Medical Devices designs, develops, manufactures and markets diverse X-ray diagnostic systems as well as components for radiology and medical clinics.

Oaklins Italy’s parent company Banca Akros acted as Euronext Growth advisor, global coordinator and joint bookrunner in this transaction.

Falar com a equipa da transação

Giulio Greco

Managing Director
Milão, Itália
Oaklins Italy

Giuliano Altieri

Director
Milão, Itália
Oaklins Italy

Marco Valsecchi

Associate
Milão, Itália
Oaklins Italy

Nicola Biancoli

Analyst
Milão, Itália
Oaklins Italy

Transações relacionadas

Winking Studios Limited completes a secondary fundraising of US$20 million
Outros setores | TMT

Winking Studios Limited completes a secondary fundraising of US$20 million

Winking Studios has successfully raised US$20 million to fund its business strategy and future plans, such as strategic acquisitions, alliances and joint ventures as well as secondary or dual listings, to grow the group’s market share and broaden its customer base globally.

Saber mais
FRP Advisory Group plc has finalized a successful secondary placing
Serviços Financeiros

FRP Advisory Group plc has finalized a successful secondary placing

FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.

Saber mais
Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Saúde

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Saber mais